CorMedix (CRMD) Other Non Operating Income (2011 - 2025)
CorMedix's (CRMD) quarterly Other Non Operating Income came in at $75195.0 in Q4 2025, up 123.95% year-on-year from $33577.1 in Q4 2024, and up 203.39% quarter-over-quarter from -$72727.0 in Q3 2025.
CorMedix (CRMD) Other Non Operating Income (2011 - 2025) Analysis & Trends
CorMedix has disclosed Other Non Operating Income across 12 years of filings, most recently posting $75195.0 for Q4 2025.
- Other Non Operating Income for Q4 2025 came in at $75195.0, up 123.95% year-over-year; the trailing twelve-month figure through Dec 2025 was -$51999.0 (down 134.98% YoY), and the FY2025 annual result was -$52000.0, down 127.96% from the prior year.
- Other Non Operating Income came in at $75195.0 for Q4 2025 at CorMedix, up from -$72727.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $500000.0 in Q2 2024 to a low of -$314000.0 in Q4 2024.
- The 5-year median for Other Non Operating Income is -$5433.5 (2021), against an average of $9752.6.
- Peak annual rise in Other Non Operating Income reached 3840.28% in 2024, while the deepest fall reached 25670.03% in 2024.
- CorMedix's Other Non Operating Income stood at -$11066.0 in 2021, then soared by 150.13% to $5547.0 in 2022, then tumbled by 77.86% to $1228.0 in 2023, then sank by 25670.03% to -$314000.0 in 2024, then soared by 123.95% to $75195.0 in 2025.
- The last three Other Non Operating Income figures came in at $75195.0 (Q4 2025), -$72727.0 (Q3 2025), and -$16295.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75,195.00 |
| Sep 30, 2025 | -72,727.00 |
| Jun 30, 2025 | -16,295.00 |
| Mar 31, 2025 | -38,172.00 |
| Dec 31, 2024 | -314,000.00 |
| Sep 30, 2024 | -33,325.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | -4,008.00 |
| Dec 31, 2023 | 1,228.00 |
| Sep 30, 2023 | -29,199.00 |
| Jun 30, 2023 | -13,368.00 |
| Mar 31, 2023 | 12,345.00 |
| Dec 31, 2022 | 5,547.00 |
| Sep 30, 2022 | 108,213.00 |
| Jun 30, 2022 | 49,989.00 |
| Mar 31, 2022 | -10,206.00 |
| Dec 31, 2021 | -11,066.00 |
| Sep 30, 2021 | -4,447.00 |
| Jun 30, 2021 | -4,233.00 |
| Mar 31, 2021 | -6,420.00 |